Donor characteristics
| . | Haplo donors . |
|---|---|
| Age in y, median (range) | 37 (8-71) |
| Group age, n (%) | |
| <40 | 1304 (59.3) |
| ≥40 | 896 (40.7) |
| Gender, n (%) | |
| Male | 1380 (62.7) |
| Female | 820 (37.3) |
| Donor/recipient gender combination, n (%) | |
| Donor female to male recipient | 458 (20.8) |
| Other | 1742 (79.2) |
| CMV serologic status, n (%) | |
| Negative | 948 (43.1) |
| Positive | 1252 (56.9) |
| Stem cell source, n (%) | |
| PB | 1631 (74.1) |
| BM | 569 (25.9) |
| Donor/recipient HLA mismatch, n (%) | |
| 2-3/8 | 562 (25.5) |
| ≥ 4/8 | 1638 (74.5) |
| . | Haplo donors . |
|---|---|
| Age in y, median (range) | 37 (8-71) |
| Group age, n (%) | |
| <40 | 1304 (59.3) |
| ≥40 | 896 (40.7) |
| Gender, n (%) | |
| Male | 1380 (62.7) |
| Female | 820 (37.3) |
| Donor/recipient gender combination, n (%) | |
| Donor female to male recipient | 458 (20.8) |
| Other | 1742 (79.2) |
| CMV serologic status, n (%) | |
| Negative | 948 (43.1) |
| Positive | 1252 (56.9) |
| Stem cell source, n (%) | |
| PB | 1631 (74.1) |
| BM | 569 (25.9) |
| Donor/recipient HLA mismatch, n (%) | |
| 2-3/8 | 562 (25.5) |
| ≥ 4/8 | 1638 (74.5) |